Submitted on July 7, 2009
Revised on September 25, 2009
Accepted on September 28, 2009
Binding partner switching on microtubules and aurora-B in the mitosis to cytokinesis transition
Nurhan Ozlu, Flavio Monigatti, Bernhard Y. Renard, Christine M. Field, Hanno Steen, Timothy J. Mitchison, and Judith J. Steen
Department of Neurobiology, Harvard Medical School and Children's Hospital Boston, Division of Neuroscience Children's Hospital Boston, Boston, MA 02115
Corresponding Author: Judith.steen{at}childrens.harvard.edu
The cytoskeleton globally reorganizes between mitosis (M-phase) and cytokinesis (C-phase), which presumably requires extensive regulatory changes. To reveal these, we undertook a comparative proteomic analysis of cells tightly drug-synchronized in each phase. We identified 25 proteins that bind selectively to microtubules in C-phase, and identified several novel binding partners including NUSAP. C-phase selective microtubule binding of many of these proteins depended on activity of Aurora kinases, as assayed by treatment with the drug VX680. Aurora-B binding partners switched dramatically between M-phase to C-phase, and we identified several novel C-phase selective Aurora B binding partners including PRC1, KIF4 and APC/C. Our approach can be extended to other cellular compartments and cell states, and our data provide the first broad biochemical framework for understanding C-phase. Concretely, we report a central role for Aurora-B in regulating the C-phase cytoskeleton.